Quality Trust

Skip

Start Investing Download Fact Sheet

Management

Tom Hancock

Head of Focused Equity

Dr. Hancock is the head of GMO’s Focused Equity team and the portfolio manager for the Quality Strategy. Previously at GMO, he was co-head of the Global Equity team. He is a partner of the firm. Prior to joining GMO in 1995, he was a research scientist at Siemens and a software engineer at IBM. Dr. Hancock holds a Ph.D. in Computer Science from Harvard University and B.S. and M.S. degrees from Rensselaer Polytechnic Institute.

Ty Cobb

Portfolio Manager

Mr. Cobb is engaged in portfolio management and research within GMO’s Focused Equity team and is a partner of the firm. Previously at GMO, he led the fundamental research group for the Global Equity team. Prior to joining GMO in 1997, he worked at Brown Brothers Harriman. Mr. Cobb received a B.A. in Economics/Russian Language from Bucknell University and an M.S. in Finance from Suffolk University. He is a CFA charterholder.

Anthony Hene

Portfolio Manager, Focused Equity

Mr. Hene is co-portfolio manager for the Quality Strategy. He is a member of the Focused Equity team and a partner of the firm. Previously at GMO, he was engaged in portfolio management within the Global Equity team. Mr. Hene joined GMO full-time in 1995. He has an MSc in Biochemistry from the University of Oxford and is a CFA charterholder.

Overview

The GMO Quality Trust seeks to generate total return by investing primarily in equities the Focused Equity team believes to be of high quality.

The team believes that companies with established track records of historical profitability and strong fundamentals – high quality companies – are able to outgrow the average company over time and are therefore worth a premium price. The Trust’s disciplined approach uses both quantitative and fundamental techniques to assess the relative quality and valuation of global companies and aims to exploit a long-term investment horizon while withstanding short-term volatility.

GMO's Quality Strategy

Facts

Doc Table
Fund Inception Date	September 23, 2020
Fund Total Assets as of 31/12/2020	$1mm USD
NAV as of 22/01/2021	1.0700

Performance

Table Caption
	QTD	YTD	ITD
Quality Trust	5.45	6.57	6.57
MSCI World	5.85	6.83	6.83

Inception Date: September 24, 2020

Returns shown for periods greater than one year are on an annualized basis.

Net returns are presented after the deduction of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

¹ The inception date of the fund is 23 September 2020. The inception date of the performance data above is 24 September 2020, the first full day that the GMO Quality Trust was fully invested. Performance data using an inception date of 23 September 2020 would produce a different outcome and compare fund performance over a period different to that reflected in the benchmark performance. The GMO QualityTrust ARSN 643 940 872 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Table Caption
	QTD	YTD	ITD
Quality Trust	5.61	6.74	6.74
MSCI World	5.85	6.83	6.83

Inception Date: September 24, 2020

Returns shown for periods greater than one year are on an annualized basis.

Gross returns are presented gross of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

¹ The inception date of the fund is 23 September 2020. The inception date of the performance data above is 24 September 2020, the first full day that the GMO Quality Trust was fully invested. Performance data using an inception date of 23 September 2020 would produce a different outcome and compare fund performance over a period different to that reflected in the benchmark performance. The GMO QualityTrust ARSN 643 940 872 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Table Caption
	MTD	QTD	YTD	ITD
Quality Trust	0.39	5.45	6.57	6.57
MSCI World	-0.46	5.85	6.83	6.83

Inception Date: September 24, 2020

Returns shown for periods greater than one year are on an annualized basis.

Net returns are presented after the deduction of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

¹ The inception date of the fund is 23 September 2020. The inception date of the performance data above is 24 September 2020, the first full day that the GMO Quality Trust was fully invested. Performance data using an inception date of 23 September 2020 would produce a different outcome and compare fund performance over a period different to that reflected in the benchmark performance. The GMO QualityTrust ARSN 643 940 872 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Table Caption
	MTD	QTD	YTD	ITD
Quality Trust	0.44	5.61	6.74	6.74
MSCI World	-0.46	5.85	6.83	6.83

Inception Date: September 24, 2020

Returns shown for periods greater than one year are on an annualized basis.

Gross returns are presented gross of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

¹ The inception date of the fund is 23 September 2020. The inception date of the performance data above is 24 September 2020, the first full day that the GMO Quality Trust was fully invested. Performance data using an inception date of 23 September 2020 would produce a different outcome and compare fund performance over a period different to that reflected in the benchmark performance. The GMO QualityTrust ARSN 643 940 872 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Calendar
	Quality Trust	MSCI World
2020	6.57	6.83

Inception Date: September 24, 2020

Returns shown for periods greater than one year are on an annualized basis.

Net returns are presented after the deduction of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

¹ The inception date of the fund is 23 September 2020. The inception date of the performance data above is 24 September 2020, the first full day that the GMO Quality Trust was fully invested. Performance data using an inception date of 23 September 2020 would produce a different outcome and compare fund performance over a period different to that reflected in the benchmark performance. The GMO QualityTrust ARSN 643 940 872 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Calendar
	Quality Trust	MSCI World
2020	6.74	6.83

Inception Date: September 24, 2020

Returns shown for periods greater than one year are on an annualized basis.

Gross returns are presented gross of management fees and incentive fees if applicable. These returns include transaction costs, commissions and withholding taxes on foreign income and capital gains and include the reinvestment of dividends and other income, as applicable.

Performance data quoted represents past performance and is not predictive of future performance.

¹ The inception date of the fund is 23 September 2020. The inception date of the performance data above is 24 September 2020, the first full day that the GMO Quality Trust was fully invested. Performance data using an inception date of 23 September 2020 would produce a different outcome and compare fund performance over a period different to that reflected in the benchmark performance. The GMO QualityTrust ARSN 643 940 872 (“the Trust”) is issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656.

Documents

Literature

Fact Sheet		Download
Information Memorandum for Wholesale Investors		Download
Product Disclosure Statements for Non-Wholesale Investors		Download
Statement of Additional Information		Download
Download All		Download

Downloads

Performance		Download
Portfolio Composition		Download
Holdings		Download
Download All		Download

Commentary & Attribution

Commentary - Quarterly		Download
Attribution - Monthly		Download
Attribution - Quarterly		Download
Attribution - YTD		Download
Download All		Download

Investor Information

NAVs and Distributions		Download
Download All		Download

Document Library

Risks

Risks associated with investing in the Fund may include Market Risk - Equities, Management and Operational Risk, Focused Investment Risk, Non-U.S. Investment Risk, and Currency Risk. For a more complete discussion of these risks and others, please consult the Trusts Product Disclosure Statement.

Disclosures

The GMO Australia Trusts (the "Trusts") are issued by GMO Australia Limited ABN 30 071 502 639, AFS Licence No. 236 656. The Trusts accept investments from wholesale investors only. Retail investors are not able to directly invest in the Trusts but may be able to gain exposure to some of the Trusts by investing with certain investor directed portfolio services, master trusts, wrap accounts or custodians ("Services"). GMO Australia Limited, GMO LLC, and their affiliates, do not guarantee the performance of any Trust or the repayment of an investor's capital.

This information is of a general nature only and is not advice. It does not take into account the objectives, financial situation or needs of any specific investor. The offer to invest in a Trust for wholesale investors is contained in the current Information Memorandum. A Product Disclosure Statement ("PDS") may be available for some of the Trusts and is solely for use by retail investors gaining exposure to a Trust through a Service. The Information Memorandum and PDS (if available) may be accessed from this website. Investors should read the Information Memorandum or PDS, consider their own circumstances, and obtain their own advice before making an investment decision.